Release Notes; Version 20180320
General Notes
The allowable status strings have been modified to add an additional status of "Deprec" (deprecated). Concepts with this status have been created in error and should not be used in systems. This change of the additional status is applicable has been made to all of the file types with a status attribute EXCEPT the Special Groupings file. Please see the Technical Specification for the details.
The following files will be available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship,
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The 'Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
The “Delta" release contains only those concepts that have been added or changed since the previous release. The type of changes would include; inactivated and changes to any description. Delta files will be provided in a future release.
The scope of this release includes most of the top 250 moieties plus additional content beyond the top 250. .
The table below provides the number of concepts within each CCDD file for this release.
| February, 2018 CCDD Files | Number of Concepts | Types of Changes in this release |
|---|---|---|
| Therapeutic Moiety Full Release | 356 | 58 additions 1 status date change |
| Non-proprietary Therapeutic Product Full Release | 1428 | 125 additions 5 concepts with formal name changes 1 status change from Inactive to Active 3 status changes from Active to Deprec (deprecated) 3 status date changes |
| Manufactured Product Full Release | 6109 | 315 additions Formal name changes made:
5 status changes 39 status date changes |
Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship | 6109 | Includes concept additions and formal name changes as above Deprecated content removed |
| Device Non-proprietary Therapeutic Product | 3 | no change |
| Special Groupings | 1076 | 76 additions (status date reflects the date this file was first generated) Includes concept additions and formal name changes as above Deprecated content removed |
| Coded Attributes | 7 | 1 addition (Narcotic (CDSA II)) |
Errors addressed in this release
The following have had their status changed in the NTP file to Deprecated (Deprec) and should no longer be used:
9009620 | furosemide 40 mg per 2 mL solution for injection ampoule |
9000145 | diazepam 20 mg per 2 mL solution for injection ampoule |
| 9000965 | ketorolac tromethamine 30 mg per mL solution for injection |
Known errors in this release
It has been brought to our attention that the following concepts are incorrect in the March release and also in past releases. The following in red are incorrect and will be changed in the April Release of the CCDD:
mp_code | mp_formal_name | ntp_code | ntp_formal_name |
02048264 | DIGOXIN INJECTION C.S.D. (digoxin 1 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED | 9006236 | digoxin 1 mg per 2 mL solution for injection ampoule |
| 02256711 | RANITIDINE INJECTION USP (ranitidine (ranitidine hydrochloride) 100 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED | 9006272 | ranitidine (ranitidine hydrochloride) 100 mg per 2 mL solution for injection vial |
| 02212366 | ZANTAC (ranitidine (ranitidine hydrochloride) 100 mg per 2 mL solution for injection vial) GLAXOSMITHKLINE INC | 9006272 | ranitidine (ranitidine hydrochloride) 100 mg per 2 mL solution for injection vial |
| 00860778 | NITROGLYCERIN INJECTION USP (nitroglycerin 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED | 9010882 | nitroglycerin 500 mg per 10 mL solution for injection vial |
| 00778869 | NITROJECT INJ 5MG/ML (nitroglycerin 500 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LTD | 9010882 | nitroglycerin 500 mg per 10 mL solution for injection vial |
The following is how they will be corrected in the April release of the CCDD
mp_code | mp_formal_name | Change |
02048264 | DIGOXIN INJECTION C.S.D. (digoxin 0.5 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED | The formal name will be changed (no change to the code) |
| 02256711 | RANITIDINE INJECTION USP (ranitidine (ranitidine hydrochloride) 50 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED | The formal name will be changed (no change to the code) |
| 02212366 | ZANTAC (ranitidine (ranitidine hydrochloride) 50 mg per 2 mL solution for injection vial) GLAXOSMITHKLINE INC | The formal name will be changed (no change to the code) |
| 00860778 | NITROGLYCERIN INJECTION USP (nitroglycerin 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED | The formal name will be changed (no change to the code) |
| 00778869 | NITROJECT INJ 5MG/ML (nitroglycerin 50 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LTD | The formal name will be changed (no change to the code) |
ntp_code | ntp_formal_name | change |
9006236 | digoxin 1 mg per 2 mL solution for injection ampoule | The status for this concept will change to "Deprec" to indicate it should no longer be used. |
| tbd | digoxin 0.5 mg per 2 mL solution for injection ampoule | A new concept will be added (with a new code and formal name created) |
| 9006272 | ranitidine (ranitidine hydrochloride) 100 mg per 2 mL solution for injection vial | The status for this concept will change to "Deprec" to indicate it should no longer be used. |
| tbd | ranitidine (ranitidine hydrochloride) 50 mg per 2 mL solution for injection vial | A new concept will be added (with a new code and formal name created) |
| 9010882 | nitroglycerin 500 mg per 10 mL solution for injection vial | The status for this concept will change to "Deprec" to indicate it should no longer be used. |
| tbd | nitroglycerin 50 mg per 10 mL solution for injection vial | A new concept will be added (with a new code and formal name created) |
Manufactured Product Specific Comments
It is the intent of the CCDD formal names to always be unique. However, in this release there are several Manufactured Product concept formal names that did not generate uniquely following the CCDD Manufactured Product naming pattern as documented in the MP Formal Name Pattern section of the Editorial Guidelines. See below for an example:
02028174 | ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC |
02025337 | ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC |
This lack of unique formal names for the Manufactured Product will be addressed via a change made to the Health Canada Drug Database over the course of the next couple of months.
Terminology Gateway Specific Comments
A link to the Release notes on this page has been added to the Gateway CCDD files. Users may use the "Change Logs" available when viewing each individual file on the Gateway. The change logs identify the additions and changes to a code or formal name only. If there has been a change to a status or status date, it will not appear in the change log at this time.
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]
Please note that to access InfoCentral, you must have an Infoway login. If you have any questions about any of our standards or products, please contact the Infodesk Desk at:
Toll Free #: 1-877-595-3417 or 416-595-3417
E-mail: [email protected]